Has MRD Monitoring Superseded Other Prognostic Factors in Adult ALL?

Track: BMT Tandem "Scientific" Meeting
Wednesday, February 13, 2013, 7:00 AM-8:00 AM
Ballroom A-H (Salt Palace Convention Center)
Daniel J. Weisdorf, MD , Masonic Cancer Center, University of Minnesota, Minneapolis, MN
See more of: BMT Tandem Breakfast Symposium: The Significance of Minimal Residual Disease in Adult ALL
See more of: BMT Tandem "Scientific" Meeting
Previous Presentation | Next Presentation >>